Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−44.10 M USD
11.99 M USD
35.04 M
About Beta Bionics, Inc.
Sector
Industry
CEO
Sean Thomas Saint
Website
Headquarters
Irvine
Founded
2015
FIGI
BBG00JNGG9Q2
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BBNX is 20.57 USD — it has decreased by −1.44% in the past 24 hours. Watch Beta Bionics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Beta Bionics, Inc. stocks are traded under the ticker BBNX.
BBNX stock has fallen by −5.29% compared to the previous week, the month change is a −6.50% fall, over the last year Beta Bionics, Inc. has showed a −6.50% decrease.
We've gathered analysts' opinions on Beta Bionics, Inc. future price: according to them, BBNX price has a max estimate of 31.00 USD and a min estimate of 20.00 USD. Watch BBNX chart and read a more detailed Beta Bionics, Inc. stock forecast: see what analysts think of Beta Bionics, Inc. and suggest that you do with its stocks.
BBNX reached its all-time high on Jan 30, 2025 with the price of 24.50 USD, and its all-time low was 21.35 USD and was reached on Feb 14, 2025. View more price dynamics on BBNX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Beta Bionics, Inc. financials in yearly and quarterly reports right on TradingView.
Beta Bionics, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
BBNX net income for the last quarter is −9.74 M USD, while the quarter before that showed −18.85 M USD of net income which accounts for 48.34% change. Track more Beta Bionics, Inc. financial stats to get the full picture.
No, BBNX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 22, 2025, the company has 277.00 employees. See our rating of the largest employees — is Beta Bionics, Inc. on this list?
Like other stocks, BBNX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Beta Bionics, Inc. stock right from TradingView charts — choose your broker and connect to your account.